Journal of Medicinal Chemistry · 2008 · 80 citations · 21 references
MedicineMedicinal ChemistryPharmacologyDrug DiscoveryNeuropharmacologyStructure-activity RelationshipsDrug-receptor InteractionsLigand BindingPotency OptimizationReceptor ModelingReceptor PharmacologySerotonergic Pharmacology5-Hydroxytryptamine 1A Receptor Agonists5-Hydroxytryptamine Receptor PharmacologyFunctional AssaysRadioligand Binding AssaysReceptorsSerotonergic Drug DiscoverySerotonergic Ligand DesignSerotonin Receptor Pharmacology
A series of new compounds containing a benzimidazole, benzothiazole, or benzoxazole nucleus linked to an arylpiperazine by different thioalkyl chains was prepared. They were tested in radioligand binding experiments to evaluate their affinity for 5-HT 1A and 5-HT 2A serotonergic, alpha 1 adrenergic, D1, and D2 dopaminergic receptors. Many of tested compounds showed an interesting binding profile; in particular, 36 displayed very high 5-HT 1A receptor affinity and selectivity over all the other investigated receptors. Selected compounds, evaluated in functional assays, showed antagonistic or partial agonistic activity at 5-HT 1A receptor. An extensive conformational research using both NMR and modeling techniques indicated that extended conformations predominated in vacuum, in solution and during interactions with 5-HT 1A receptor. Finally, the elaborated binding mode of selected compounds at 5-HT 1A receptor was used to explain the influence of spacer length on ligands affinity.
21
Timo Heinrich, Henning Böttcher, R. Gericke et al. · Journal of Medicinal Chemistry · 2004 · 116 citations · Full text